These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
430 related articles for article (PubMed ID: 35230418)
1. Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines. Pritchard D; Patel JN; Stephens LE; McLeod HL Am J Health Syst Pharm; 2022 Jun; 79(12):993-1005. PubMed ID: 35230418 [TBL] [Abstract][Full Text] [Related]
2. ADME Gene-Related Pharmacogenomic Labeling of FDA-Approved Drugs: Comparison with Clinical Pharmacogenetics Implementation Consortium (CPIC) Evidence Levels. Deb S; Hopefl R; Reeves AA; Cvetkovic D Medicines (Basel); 2024 Feb; 11(3):. PubMed ID: 38535119 [TBL] [Abstract][Full Text] [Related]
3. Discrepancies and similarities in the genome-informed guidance for psychiatric disorders amongst different regulatory bodies and research consortia using next generation sequencing-based clinical pharmacogenomics data. Kordou Z; Skokou M; Tsermpini EE; Chantratita W; Fukunaga K; Mushiroda T; Patrinos GP; Koromina M Pharmacol Res; 2021 May; 167():105538. PubMed ID: 33705851 [TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomic information from CPIC and DPWG guidelines and its application on drug labels. Yoon DY; Lee S; Ban MS; Jang IJ; Lee S Transl Clin Pharmacol; 2020 Dec; 28(4):189-198. PubMed ID: 33425802 [TBL] [Abstract][Full Text] [Related]
5. Retrospective Review of Pharmacogenetic Testing at an Academic Children's Hospital. Roberts TA; Wagner JA; Sandritter T; Black BT; Gaedigk A; Stancil SL Clin Transl Sci; 2021 Jan; 14(1):412-421. PubMed ID: 33048453 [TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics in Child and Adolescent Psychiatry: Background and Evidence-Based Clinical Applications. Malik S; Verma P; Ruaño G; Al Siaghy A; Dilawar A; Bishop JR; Strawn JR; Namerow LB J Child Adolesc Psychopharmacol; 2024 Feb; 34(1):4-20. PubMed ID: 38377525 [TBL] [Abstract][Full Text] [Related]
7. Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population. Verma SS; Keat K; Li B; Hoffecker G; Risman M; ; Sangkuhl K; Whirl-Carrillo M; Dudek S; Verma A; Klein TE; Ritchie MD; Tuteja S J Transl Med; 2022 Nov; 20(1):550. PubMed ID: 36443877 [TBL] [Abstract][Full Text] [Related]
8. Prescription Patterns and Relationship to Pharmacogenomics Testing in the Military Health System. Selig DJ; Livezey JR; Chin GC; DeLuca JP; Guillory Ii WO; Kress AT; Oliver TO; Por ED Mil Med; 2021 Dec; 187(Suppl 1):9-17. PubMed ID: 34967405 [TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet? Verbelen M; Weale ME; Lewis CM Pharmacogenomics J; 2017 Oct; 17(5):395-402. PubMed ID: 28607506 [TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomic biomarkers in drug labels: what do they tell us? Tutton R Pharmacogenomics; 2014 Feb; 15(3):297-304. PubMed ID: 24533709 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of population-level pharmacogenetic actionability in Alabama. Davis BH; Williams K; Absher D; Korf B; Limdi NA Clin Transl Sci; 2021 Nov; 14(6):2327-2338. PubMed ID: 34121327 [TBL] [Abstract][Full Text] [Related]
13. Assessing Clinical Utility of Pharmacogenetic Testing in the Military Health System. Hellwig LD; Turner C; Olsen C; Libbus J; Markos B; Koehlmoos T; Haigney M; De Castro M; Saunders D Mil Med; 2024 Jan; 189(1-2):e198-e204. PubMed ID: 37436924 [TBL] [Abstract][Full Text] [Related]
14. Thoughtful Clinical Use of Pharmacogenetics in Child and Adolescent Psychopharmacology. Ramsey LB; Namerow LB; Bishop JR; Hicks JK; Bousman C; Croarkin PE; Mathews CA; Van Driest SL; Strawn JR J Am Acad Child Adolesc Psychiatry; 2021 Jun; 60(6):660-664. PubMed ID: 32860906 [TBL] [Abstract][Full Text] [Related]
15. Opportunities for Pharmacogenetic Testing to Guide Dosing of Medications in Youths With Medicaid. Tang Girdwood S; Hall M; Antoon JW; Kyler KE; Williams DJ; Shah SS; Orth LE; Goldman J; Feinstein JA; Ramsey LB JAMA Netw Open; 2024 Feb; 7(2):e2355707. PubMed ID: 38349656 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of exposure to pharmacogenetic drugs by the Saudis treated at the health care centers of the Ministry of National Guard. Alshabeeb MA; Alyabsi M; Paras B Saudi Pharm J; 2022 Aug; 30(8):1181-1192. PubMed ID: 36164570 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of pharmacogenomic evidence for drugs related to Reeves AA; Hopefl R; Deb S Drug Metab Pers Ther; 2023 Mar; 38(1):65-78. PubMed ID: 36257916 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular pharmacogenomics; state of current knowledge and implementation in practice. Shahabi P; Dubé MP Int J Cardiol; 2015 Apr; 184():772-795. PubMed ID: 25838112 [TBL] [Abstract][Full Text] [Related]
19. Evidence and resources to implement pharmacogenetic knowledge for precision medicine. Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205 [TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics in Practice: Estimating the Clinical Actionability of Pharmacogenetic Testing in Perioperative and Ambulatory Settings. Smith DM; Peshkin BN; Springfield TB; Brown RP; Hwang E; Kmiecik S; Shapiro R; Eldadah Z; Lundergan C; McAlduff J; Levin B; Swain SM Clin Transl Sci; 2020 May; 13(3):618-627. PubMed ID: 31961467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]